DMCC Speciality

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE505A01010
  • NSEID: DMCC
  • BSEID: 506405
INR
288.70
10.9 (3.92%)
BSENSE

May 06

BSE+NSE Vol: 1.09 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.09 lacs (88.38%) Volume

Shareholding (Mar 2026)

FII

0.13%

Held by 2 FIIs

DII

1.26%

Held by 1 DIIs

Promoter

53.84%

how big is DMCC Speciality?

06-Jun-2025

As of Jun 06, DMCC Speciality Chemicals Ltd has a market capitalization of 668.39 Cr, classifying it as a Micro Cap company, with recent net sales of 431.31 Cr and a net profit of 21.52 Cr over the last four quarters. The latest balance sheet shows shareholder's funds at 209.54 Cr and total assets of 364.72 Cr.

Market Cap: As of Jun 06, DMCC Speciality Chemicals Ltd has a market capitalization of 668.39 Cr, which classifies it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest 4 quarters, the sum of Net Sales is 431.31 Cr and the sum of Net Profit is 21.52 Cr. This data is presented on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: This is also on a Consolidated basis for the latest annual period ending in Mar'24. The Shareholder's Funds are reported at 209.54 Cr, and the Total Assets amount to 364.72 Cr.

View full answer

Who are in the management team of DMCC Speciality?

06-Jun-2025

As of March 2023, the management team of DMCC Speciality includes Laxmikumar N Goculdas (Chairman), Dilip Trimbak Gokhale (Whole-time Director), Bimal L Goculdas (Managing Director & CEO), and several independent directors, overseeing the company's operations and strategy.

As of March 2023, the management team of DMCC Speciality consists of the following individuals:<BR><BR>1. Laxmikumar N Goculdas - Chairman (Non-Executive)<BR>2. Dilip Trimbak Gokhale - Whole-time Director<BR>3. M T Ankleshwaria - Independent Director<BR>4. Mitika Laxmikumar Goculdas - Vice Chairperson<BR>5. Sanjeev Vishwanath Joshi - Independent Director<BR>6. Mukul Manoharlal Taly - Independent Director<BR>7. Bimal L Goculdas - Managing Director & CEO<BR>8. Janaki Ashwin Patwardhan - Independent Director<BR>9. Omkar Chandrakant Mhamunkar - Company Secretary & Compliance Officer<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

View full answer

What does DMCC Speciality do?

06-Jun-2025

DMCC Speciality Chemicals Ltd, established in 1919 and rebranded in 2022, operates in the specialty chemicals sector with a market cap of Rs 668 Cr, reporting net sales of 125 Cr and a net profit of 6 Cr for Q1 2025. Key metrics include a P/E ratio of 31.00 and a dividend yield of 0.37%.

Overview:<BR>DMCC Speciality Chemicals Ltd is a pioneer in the specialty chemicals industry and operates within the micro-cap market segment.<BR><BR>History:<BR>The company was incorporated in 1919 as 'Dharamsi Morarji Chemicals Company Limited' and changed its name to 'DMCC Speciality Chemicals Limited' on August 12, 2022. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 125 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 6 Cr (Quarterly Results - Mar 2025)<BR>- Market-cap: Rs 668 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 31.00<BR>- Industry P/E: 47<BR>- Dividend Yield: 0.37%<BR>- Debt Equity: 0.18<BR>- Return on Equity: 9.46%<BR>- Price to Book: 2.96<BR><BR>Contact Details:<BR>Address: Prospect Chambers, 317/21 Dr D N Road Fort Mumbai Maharashtra : 400001<BR>Tel: 91-22-22048881/2/3<BR>Email: dgokhale@dmcc.com<BR>Website: http://www.dmcc.com

View full answer

Has DMCC Speciality declared dividend?

06-Jun-2025

Yes, DMCC Speciality Chemicals Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of August 28, 2024. While the company shows significant volatility in total returns over shorter periods, it has achieved a total return of 235.49% over the past five years.

DMCC Speciality Chemicals Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1<BR>- Ex-date: 28 Aug 24<BR><BR>Dividend Yield: 0.37%.<BR><BR>Total Returns by Period:<BR>Over the last 6 months, the price return was -29.58%, with a dividend return of 0%, resulting in a total return of -29.58%.<BR><BR>In the past year, the price return was -13.21%, the dividend return was 0.31%, leading to a total return of -12.9%.<BR><BR>Over two years, the price return was 4.57%, with a dividend return of 0.37%, resulting in a total return of 4.94%.<BR><BR>For the three-year period, the price return was -26.25%, the dividend return was 0.62%, culminating in a total return of -25.63%.<BR><BR>In the four-year timeframe, the price return was -18.72%, with a dividend return of 0.77%, leading to a total return of -17.95%.<BR><BR>Finally, over five years, the price return was 230.67%, the dividend return was 4.82%, resulting in a total return of 235.49%.<BR><BR>Overall, while DMCC Speciality has declared a dividend, the total returns over various periods show significant volatility, with a notable decline in returns over shorter periods, contrasting with strong returns over the longer five-year horizon.

View full answer

Who are the peers of the DMCC Speciality?

03-Jun-2025

DMCC Speciality's peers include Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Amal, Kronox Lab, Sunshield Chem., and Plastiblends (I). In terms of returns, DMCC Speciality has a 1-year return of -15.66%, lower than its peers, with Amal showing the highest return at 49.47%.

Peers: The peers of DMCC Speciality are Pidilite Inds., SRF, Gujarat Fluoroch, Deepak Nitrite, Himadri Special, Amal, Kronox Lab, Sunshield Chem., and Plastiblends (I).<BR><BR>Quality Snapshot: Excellent management risk is observed at Deepak Nitrite, while Good management risk is found at Pidilite Inds. and SRF. Average management risk is present at Gujarat Fluoroch, Himadri Special, DMCC Speciality, Amal, Kronox Lab, Sunshield Chem., and Black Rose Indus. Growth is classified as Good for Himadri Special and Amal, Average for Pidilite Inds. and SRF, and Below Average for Gujarat Fluoroch, Deepak Nitrite, DMCC Speciality, Kronox Lab, Sunshield Chem., Plastiblends (I), and Black Rose Indus. Capital Structure is Excellent for Pidilite Inds., SRF, Deepak Nitrite, and Plastiblends (I), Good for Gujarat Fluoroch, Himadri Special, and DMCC Speciality, Average for Amal, and Below Average for Sunshield Chem.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Amal at 49.47%, while the lowest is Deepak Nitrite at -9.64%. DMCC Speciality's 1-year return is -15.66%, which is lower than both. Additionally, the six-month return is negative for Deepak Nitrite, Himadri Special, DMCC Speciality, Kronox Lab, Sunshield Chem., and Black Rose Indus.

View full answer

Who are the top shareholders of the DMCC Speciality?

17-Jul-2025

The top shareholder of DMCC Speciality is Laxmikumar Narottam Goculdas, holding 36.27%, followed by individual investors with 33.75%. Other notable shareholders include Girish Gulati (HUF) at 2.28%, with minimal holdings from mutual funds (0.01%) and foreign institutional investors (1.16%).

The top shareholders of DMCC Speciality include Laxmikumar Narottam Goculdas, who holds the largest share at 36.27%. The company is primarily owned by promoters, with no pledged promoter holdings reported. Additionally, there are individual investors who collectively hold 33.75% of the shares. The highest public shareholder is Girish Gulati (HUF), with a holding of 2.28%. The company also has a small percentage of shares held by mutual funds (0.01%) and foreign institutional investors (1.16%) across six different entities.

View full answer

Is DMCC Speciality overvalued or undervalued?

20-Nov-2025

As of November 19, 2025, DMCC Speciality is considered very attractive and undervalued compared to peers in the specialty chemicals sector, with favorable key ratios indicating strong growth potential despite a recent year-to-date return of -27.89%.

As of 19 November 2025, the valuation grade for DMCC Speciality has moved from attractive to very attractive, indicating a significant improvement in its perceived value. The company is currently considered undervalued, especially when compared to its peers in the specialty chemicals sector. Key ratios include a PE ratio of 23.89, an EV to EBITDA of 11.02, and a PEG ratio of 0.22, which suggests strong growth potential relative to its price.<BR><BR>In comparison with peers, DMCC Speciality's valuation stands out favorably against companies like Solar Industries, which has a PE ratio of 94.38, and Gujarat Fluoroch, with a PE ratio of 56.8, both categorized as very expensive. This stark contrast highlights DMCC's relative attractiveness in the market. Despite recent underperformance with a year-to-date return of -27.89% compared to the Sensex's 9.02%, the fundamental metrics suggest that DMCC Speciality is positioned well for future growth and recovery.

View full answer

How has been the historical performance of DMCC Speciality?

04-Dec-2025

DMCC Speciality's historical performance shows significant growth in net sales and profitability, with net sales rising from INR 327.95 crore in March 2024 to INR 431.30 crore in March 2025, and profit after tax increasing to INR 21.53 crore. However, rising raw material costs impacted overall expenditure, while total assets and liabilities remained stable.

Answer:<BR>The historical performance of DMCC Speciality shows a mixed trend across various financial metrics over the years.<BR><BR>Breakdown:<BR>DMCC Speciality's net sales increased significantly from INR 327.95 crore in March 2024 to INR 431.30 crore in March 2025, following a dip to INR 386.65 crore in March 2023. The total operating income mirrored this trend, reaching INR 431.30 crore in March 2025. However, raw material costs also rose to INR 259.09 crore in March 2025, up from INR 195.51 crore in March 2024, contributing to a total expenditure of INR 374.28 crore. This resulted in an operating profit (PBDIT) of INR 58.36 crore for March 2025, an increase from INR 46.71 crore in the previous year. Profit before tax also improved to INR 31.14 crore in March 2025, compared to INR 17.25 crore in March 2024, leading to a profit after tax of INR 21.53 crore. The company's earnings per share rose to INR 8.63 in March 2025 from INR 4.65 in March 2024. On the balance sheet, total assets increased to INR 371.92 crore in March 2025, while total liabilities were INR 371.92 crore, indicating a stable financial position. Cash flow from operating activities remained steady at INR 38 crore in March 2025, with a net cash inflow of INR 1 crore. Overall, DMCC Speciality demonstrated growth in sales and profitability, despite rising costs and fluctuating cash flows.

View full answer

Is DMCC Speciality technically bullish or bearish?

05-Dec-2025

As of December 4, 2025, DMCC Speciality is in a bearish trend with strong indications of weakness, supported by bearish MACD readings, moving averages, and KST across multiple time frames.

As of 4 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a strong indication of weakness. The weekly and monthly MACD readings are both bearish, reinforcing the negative outlook. The daily moving averages also confirm a bearish trend. Additionally, the KST is bearish on both weekly and monthly time frames, while the Bollinger Bands and OBV show mildly bearish conditions on the weekly. Overall, the combination of these indicators suggests a significant bearish sentiment for DMCC Speciality.

View full answer

When is the next results date for DMCC Speciality Chemicals Ltd?

30-Jan-2026

The next results date for DMCC Speciality Chemicals Ltd is 06 February 2026.

The next results date for DMCC Speciality Chemicals Ltd is scheduled for 06 February 2026.

View full answer

Are DMCC Speciality Chemicals Ltd latest results good or bad?

07-Feb-2026

DMCC Speciality Chemicals Ltd's latest results show strong revenue growth with net sales up 27.81% year-on-year, but a significant decline in net profit by 21.60% and a sharp drop in operating margin indicate serious profitability challenges, leading to a cautious outlook and a "SELL" rating for the stock.

DMCC Speciality Chemicals Ltd's latest results present a mixed picture. On one hand, the company achieved impressive revenue growth, with net sales reaching ₹150.87 crores in Q3 FY26, marking a 27.81% increase year-on-year and a 19.71% increase quarter-on-quarter. This is the highest quarterly revenue in the company's recent history, indicating strong topline momentum.<BR><BR>However, the profitability aspect raises concerns. The net profit for the quarter was ₹6.17 crores, which represents a significant decline of 21.60% compared to the same quarter last year, despite a 7.30% increase from the previous quarter. Additionally, the operating margin has compressed sharply to 9.76%, down from 15.02% a year ago, reflecting substantial cost pressures and operational challenges.<BR><BR>Overall, while the revenue growth is commendable, the decline in net profit and the significant margin compression suggest that the company is facing serious profitability challenges. This has led to a cautious outlook, with the stock currently rated in the "SELL" territory due to concerns about near-term profitability and sustainability.

View full answer

Should I buy, sell or hold DMCC Speciality Chemicals Ltd?

20-Apr-2026

Why is DMCC Speciality Chemicals Ltd falling/rising?

05-May-2026

As of 05-May, DMCC Speciality Chemicals Ltd's stock price is Rs 277.80, down 2.71%, and has underperformed its sector by 4%. Despite a recent decline, investor interest is increasing, suggesting potential for future recovery.

As of 05-May, DMCC Speciality Chemicals Ltd is experiencing a decline in its stock price, currently at Rs 277.80, which reflects a decrease of Rs 7.75 or 2.71%. This downward movement is evident in today's performance, where the stock has underperformed its sector by 4%. The stock reached an intraday low of Rs 276.2, marking a decrease of 3.27% during the trading day.<BR><BR>In the context of broader market performance, the stock has shown mixed results over different periods. While it has increased by 31.85% over the past month, it has fallen by 2.27% over the past week, contrasting with the Sensex, which has gained 0.17% in the same timeframe. Year-to-date, the stock is up 9.07%, while the Sensex has declined by 9.63%. However, over the longer term, the stock has underperformed, with a 1-year decline of 7.09% compared to the Sensex's 4.68% drop, and a 5-year decline of 11.88% against the Sensex's significant gain of 58.22%.<BR><BR>Despite the current decline, there has been a notable increase in investor participation, with delivery volume rising by 47.66% against the 5-day average. This suggests that while the stock price is currently falling, there is a growing interest among investors, which could indicate potential for recovery in the future. However, the stock's performance today, along with its recent trends, primarily reflects a downward trajectory.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Company has a Debt to Equity ratio (avg) of 0.31 times

 
2

Poor long term growth as Operating profit has grown by an annual rate 15.38% of over the last 5 years

 
3

The company has declared Positive results for the last 6 consecutive quarters

4

With ROCE of 17.4, it has a Attractive valuation with a 2.8 Enterprise value to Capital Employed

5

Despite the size of the company, domestic mutual funds hold only 0.02% of the company

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

INR 693 Cr (Micro Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

42

stock-summary
Dividend Yield

0.90%

stock-summary
Debt Equity

0.16

stock-summary
Return on Equity

11.89%

stock-summary
Price to Book

2.95

Revenue and Profits:
Net Sales:
151 Cr
(Quarterly Results - Dec 2025)
Net Profit:
6 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.9%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
28.88%
0%
28.88%
6 Months
-1.6%
0%
-1.6%
1 Year
1.91%
0.90%
2.81%
2 Years
-13.23%
1.11%
-12.12%
3 Years
-1.79%
1.36%
-0.43%
4 Years
-28.81%
1.15%
-27.66%
5 Years
-8.55%
1.51%
-7.04%

Latest dividend: 2.5 per share ex-dividend date: Aug-22-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Credit Rating

04-May-2026 | Source : BSE

Credit Rating Intimation

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

28-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyDMCC Speciality Chemicals Ltd
2CIN NO.L24110MH1919PLC000564
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 47.17
4Highest Credit Rating during the previous FY CRISILBBB+STABLE
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD.
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. YES



Name of the Company Secretary: Pallavi Pednekar
Designation: Company Secretary and Compliance Officer
EmailId: ppednekar@dmcc.com
Name of the Chief Financial Officer: Sunil Kumar Goyal
Designation: Chief Finance Officer
EmailId: sgoyal@dmcc.com

Date: 28/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Reply To Clarification On Significant Increase In The Price Of Security Across Exchanges In Recent Past Sought By BSE Limited.

17-Apr-2026 | Source : BSE

As per attachment.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

DMCC Speciality Chemicals Ltd has declared 25% dividend, ex-date: 22 Aug 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
23.69%
EBIT Growth (5y)
15.38%
EBIT to Interest (avg)
5.02
Debt to EBITDA (avg)
1.58
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
1.31
Tax Ratio
30.25%
Dividend Payout Ratio
28.96%
Pledged Shares
0
Institutional Holding
1.40%
ROCE (avg)
11.07%
ROE (avg)
8.81%

Valuation key factors

Factor
Value
P/E Ratio
28
Industry P/E
42
Price to Book Value
3.09
EV to EBIT
17.06
EV to EBITDA
12.53
EV to Capital Employed
2.81
EV to Sales
1.44
PEG Ratio
1.08
Dividend Yield
0.86%
ROCE (Latest)
17.39%
ROE (Latest)
11.89%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.01%)

FIIs

Held by 2 FIIs (0.13%)

Promoter with highest holding

Laxmikumar Narottam Goculdas (36.27%)

Highest Public shareholder

Girish Gulati (huf) (2.28%)

Individual Investors Holdings

33.03%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 27.81% vs 46.58% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -21.60% vs 2,438.71% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "150.87",
          "val2": "118.04",
          "chgp": "27.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.72",
          "val2": "17.73",
          "chgp": "-16.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.31",
          "val2": "2.53",
          "chgp": "-8.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.17",
          "val2": "7.87",
          "chgp": "-21.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.76%",
          "val2": "15.02%",
          "chgp": "-5.26%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 34.58% vs 16.00% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 88.16% vs 30.31% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "253.07",
          "val2": "188.04",
          "chgp": "34.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "30.87",
          "val2": "24.16",
          "chgp": "27.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.93",
          "val2": "5.78",
          "chgp": "-32.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.51",
          "val2": "7.18",
          "chgp": "88.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.20%",
          "val2": "12.85%",
          "chgp": "-0.65%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 31.97% vs 26.15% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 30.76% vs 158.59% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "403.94",
          "val2": "306.08",
          "chgp": "31.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "45.59",
          "val2": "41.89",
          "chgp": "8.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.24",
          "val2": "8.31",
          "chgp": "-24.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "19.68",
          "val2": "15.05",
          "chgp": "30.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.29%",
          "val2": "13.69%",
          "chgp": "-2.40%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 31.51% vs -15.18% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 85.76% vs 67.24% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "431.30",
          "val2": "327.95",
          "chgp": "31.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "57.02",
          "val2": "36.27",
          "chgp": "57.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.50",
          "val2": "13.76",
          "chgp": "-23.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "21.53",
          "val2": "11.59",
          "chgp": "85.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.22%",
          "val2": "11.06%",
          "chgp": "2.16%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
150.87
118.04
27.81%
Operating Profit (PBDIT) excl Other Income
14.72
17.73
-16.98%
Interest
2.31
2.53
-8.70%
Exceptional Items
0.00
0.00
Consolidate Net Profit
6.17
7.87
-21.60%
Operating Profit Margin (Excl OI)
9.76%
15.02%
-5.26%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 27.81% vs 46.58% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -21.60% vs 2,438.71% in Dec 2024

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
253.07
188.04
34.58%
Operating Profit (PBDIT) excl Other Income
30.87
24.16
27.77%
Interest
3.93
5.78
-32.01%
Exceptional Items
0.00
0.00
Consolidate Net Profit
13.51
7.18
88.16%
Operating Profit Margin (Excl OI)
12.20%
12.85%
-0.65%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 34.58% vs 16.00% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 88.16% vs 30.31% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
403.94
306.08
31.97%
Operating Profit (PBDIT) excl Other Income
45.59
41.89
8.83%
Interest
6.24
8.31
-24.91%
Exceptional Items
0.00
0.00
Consolidate Net Profit
19.68
15.05
30.76%
Operating Profit Margin (Excl OI)
11.29%
13.69%
-2.40%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 31.97% vs 26.15% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 30.76% vs 158.59% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
431.30
327.95
31.51%
Operating Profit (PBDIT) excl Other Income
57.02
36.27
57.21%
Interest
10.50
13.76
-23.69%
Exceptional Items
0.00
0.00
Consolidate Net Profit
21.53
11.59
85.76%
Operating Profit Margin (Excl OI)
13.22%
11.06%
2.16%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 31.51% vs -15.18% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 85.76% vs 67.24% in Mar 2024

stock-summaryCompany CV
About DMCC Speciality Chemicals Ltd stock-summary
stock-summary
DMCC Speciality Chemicals Ltd
Micro Cap
Specialty Chemicals
DMCC Speciality Chemicals Limited was erstwhile incorporated as 'Dharamsi Morarji Chemicals Company Limited' on September 25, 1919. The Company changed the name from 'Dharamsi Morarji Chemicals Company Limited' to 'DMCC Speciality Chemicals Limited' on August 12, 2022. Promoted by the Late Ratansi D Morarji to manufacture chemicals at Ambernath, Company is a pioneer in the Indian chemical industry.
Company Coordinates stock-summary
Company Details
Prospect Chambers, 317/21 Dr D N Road Fort Mumbai Maharashtra : 400001
stock-summary
Tel: 91-22-22048881/2/3
stock-summary
dgokhale@dmcc.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai